General Information of Drug Formulation (ID: F13020)

Formulation Name
Meperidine 50 mg tablet
Company
Barr Laboratories; Caraco Pharmaceutical Laboratories; Teva Pharmaceuticals
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Meperidine DMX4GND Pain MG30-MG3Z Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Carmellose sodium E00625 Not Available Disintegrant
Lactose monohydrate E00393 104938 Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate E00208 11177 lubricant